KEI efforts to address pricing and other public interest issues in more than 22 different NIH licensing cases, involving both patents and data rights, are here: /nih-licenses
Our work on the Sanofi/Army Zika vaccine license is here. /zika
Xtandi is an Army and NIH funded invention, patented by UCLA. Our work on the efforts to get the Army or the NIH to use their march-in or royalty free license rights to obtain lower prices are collected here: /xtandi
The work on government funded CRISPR inventions is here: /crispr
The Fabrazyme patent disputes are here: /fabry
The 2004 and 2012 ritonavir cases are here: /ritonavir
Many of the other disputes and commentary on government funded inventions are listed below.